Volume 9 Issue 2 - International Pharmaceutical Industry

Current Edition

Editorial Archive

Crunch Time: The Impact of Serialisation Requirements on Packaging Operations

The November deadline for including unique product identifiers on prescription drugs is putting a strain on multiple parts of the industry, much of which is ill-p...

27 July 2017 Editorial Archive | Packaging | Volume 9 Issue 2

Continue Reading →

Editorial Archive

From Concept to Solution: Designing to Enhance the Multiple Roles of Pharma Packaging

When you walk into a store or pharmacy and see multiple similar products in the same competitive space, it is easy to understand the impact that packaging design ...

27 July 2017 Editorial Archive | Packaging | Volume 9 Issue 2

Continue Reading →

Editorial Archive

Mitigating Risk Roche’s Approach to PAT Implementation in a Sodium Borohydride Product

Many compounds are synthesised from raw materials in multi-batch and multi-ton quantities over extended time periods. The repetitious nature of the multi-batch bu...

27 July 2017 Editorial Archive | Manufacturing | Volume 9 Issue 2

Continue Reading →

Editorial Archive

Innovations for Prefillable Syringes

The field of prefillable syringes is constantly turning up new trends and developments, driven by new active ingredients and a desire for patient safety at afford...

27 July 2017 Editorial Archive | Manufacturing | Volume 9 Issue 2

Continue Reading →

Editorial Archive

Future Supply Chain Trends: The Rise of the Full-service CDMO

Outsourcing is on the rise, not only among big pharmaceutical firms but also with smaller emerging and even virtual companies, meaning customer requirements are ...

27 July 2017 Editorial Archive | Labs/Logistics and Cold Chain Supply | Volume 9 Issue 2

Continue Reading →

Editorial Archive

Environmental Monitoring and Reporting Facilitated by LIMS

Environmental monitoring (EM) is an essential part of any pharmaceutical, medical device or biotechnology manufacturing process. It ensures that microbiological a...

27 July 2017 Editorial Archive | Labs/Logistics and Cold Chain Supply | Volume 9 Issue 2

Continue Reading →

Editorial Archive

The Advantages of LC/MS in Identifying Residual Impurities in Biopharmaceuticals

Fergus Hall, PhD, Section Manager, Pharmaceutical Chemistry at Eurofins BioPharma Product Testing, looks at the complexity of detecting and quantifying residual i...

27 July 2017 Editorial Archive | Labs/Logistics and Cold Chain Supply | Volume 9 Issue 2

Continue Reading →

Editorial Archive

Working with Difficult Preparations – Risks, Regulations, and Considerations

Safety testing is a crucial part of drug development and is dictated by pharmacopoeial guidelines, which must be followed when performing each step of the process...

27 July 2017 Editorial Archive | Labs/Logistics and Cold Chain Supply | Volume 9 Issue 2

Continue Reading →

Editorial Archive

Propelling Holistic Risk Management Using a Next-generation RBM Approach

As the nature of clinical trials grows ever more complex, the requirement for an improved risk-based monitoring (RBM) approach increases. Such an approach improve...

27 July 2017 Editorial Archive | Special Feature | Volume 9 Issue 2

Continue Reading →

Editorial Archive

Will Graph Database Technology Uncover Pharma’s Hidden Insights?

By definition, medical research is about dealing with large quantities of data. That’s even truer in the leading edges of the life sciences, where tackling the th...

27 July 2017 Editorial Archive | Special Feature | Volume 9 Issue 2

Continue Reading →